Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae

Vaccine ◽  
2007 ◽  
Vol 25 (48) ◽  
pp. 8154-8162 ◽  
Author(s):  
Julie A. Preston ◽  
Ama-Tawiah Essilfie ◽  
Jay C. Horvat ◽  
Margaret A. Wade ◽  
Kenneth W. Beagley ◽  
...  
Keyword(s):  
Streptococcus Pneumoniae ◽  
Immunomodulatory Therapy

Impacto de los serotipos 22F y 33F en la epidemiología y patogénesis de Streptococcus pneumoniae causantes de enfermedad neumocócica invasiva en España

Vacunas ◽  
2019 ◽  
Vol 20 ◽  
pp. 36
Author(s):  
J. Sempere ◽  
F. González-Camacho ◽  
M.D. Vicioso ◽  
I. del Río Menéndez ◽  
J. Yuste ◽  
...  
Keyword(s):  
Streptococcus Pneumoniae

Der terminale Komplementkomplex ist für die Ausbildung einer suffizienten Immunantwort gegen Streptococcus pneumoniae im ZNS notwendig

2008 ◽  
Vol 35 (S 01) ◽  
Author(s):  
B Obermaier ◽  
B Angele ◽  
T Hughes ◽  
H.W Pfister ◽  
P.B Morgan ◽  
...  
Keyword(s):  
Streptococcus Pneumoniae

Streptococcus pneumoniae induziert über die Abnahme des intrazellulären Glutathione einen oxidativen Stress in den Atemwegsepithelien

Pneumologie ◽  
2011 ◽  
Vol 65 (S 01) ◽  
Author(s):  
Y Kim ◽  
J Zahlten ◽  
A Hocke ◽  
N Suttorp ◽  
S Hippenstiel ◽  
...  
Keyword(s):  
Streptococcus Pneumoniae

Rituximab and Cyclophosphamide as an alternative in immunomodulatory therapy in Rasmussen encephalitis

2013 ◽  
Vol 44 (02) ◽  
Author(s):  
M Prüfer ◽  
G Hahn ◽  
D Friebel ◽  
N Holert ◽  
B Novotná ◽  
...  
Keyword(s):  
Immunomodulatory Therapy ◽  
Rasmussen Encephalitis
Sign in / Sign up

Export Citation Format

Share Document